NACDS In Brief
This article was originally published in The Tan Sheet
Executive Summary
Mentholatum vapor patches: Mentholatum is pulling itsWellPatch Cough and Cold Soothing Vapor Pad from the marketplace following a limited distribution launch and "weak retailer acceptance," the company said at the National Association of Chain Drug Stores Marketplace tradeshow and conference in San Diego, Calif. June 24-27. The patch was indicated for temporary relief of throat and bronchial irritation associated with a cold and provided medicated vapors that would provide relief for up to eight hours. The firm maintains that the product was not pulled for safety reasons. Novartis recently recalled its Triaminic Vapor Patch after adverse events showed the product could be linked to seizures 1("The Tan Sheet" June 26, 2006, p. 8). Mentholatum is, however, gearing up to launch WellPatch Fever. Indicated for fever reduction for both children and adults, a four-count package will be offered for $3.99...